XML 36 R25.htm IDEA: XBRL DOCUMENT
v3.26.1

Segment Information | 6 Months Ended
--- | ---
Jul. 03, 2026
Segment Reporting [Abstract] |
Segment Information | SEGMENT INFORMATION The Company operates and reports its results in two business segments, the Specialty Products & Technologies and Equipment & Consumables segments. The Company’s Specialty Products & Technologies products primarily include implants, regenerative products, prosthetics, orthodontic brackets, aligners, lab products, and loupes. The Company’s Equipment & Consumables products primarily include traditional consumable products such as bonding agents and cements, rotary burs, impression materials, infection prevention products, restorative products and endodontic systems and related products while the Company’s equipment products primarily include digital imaging systems, software, and services. The Company’s operating segments are also its reportable segments. The Company’s chief operating decision maker (“CODM”) is the chief executive officer. The CODM uses segment operating profit as a key measure in evaluating the operating performance of each reportable segment, including comparisons to prior-year results, budgets, and forecasts. Segment operating profit is also utilized in the allocation of resources among segments, including the assessment of investment priorities, capital expenditures, and other operating resources. Operating profit represents total revenues less expenses, excluding corporate and other expenses, nonoperating income (expense), interest expense and income taxes. There is no disaggregated segment-level expense information that is provided regularly to the CODM that is used to assess segment performance or to allocate resources. The expense information that is regularly provided to the CODM is prepared on a consolidated basis. The expense components used in determining operating profit include the following: Cost of sales which includes the cost of materials, labor, facilities, restructuring costs and other infrastructure used to manufacture the Company’s products, and shipping and handling costs attributable to delivering these products to customers. Selling, General & Administrative expenses which includes, among other things, the costs of selling, marketing, promotion, advertising and administration (including business technology, facilities, legal, finance, human resources, business development and procurement), restructuring costs, and amortization expense for intangible assets that have been acquired through business combinations. Research and development (“R&D”) expenses which include project costs specific to new product R&D and product lifecycle management, overhead costs associated with R&D operations, regulatory costs, product registrations and investments that support local market clinical trials for approved indications. For corporate and other, these expenses represent unallocated corporate costs and other costs, including goodwill and intangible impairment charges. These activities do not meet the criteria for a stand-alone reporting segment under ASC 280 Segment Reporting, thus are not considered in management’s evaluation of reportable segment operating performance. The identifiable assets by segment are those used in each segment’s operations. Additionally, inter-segment amounts which have been eliminated are not significant to the below presentation of segment information. Segment related information is shown below ($ in millions):
| Three Months Ended July 3, 2026 |  | Three Months Ended June 27, 2025
| Specialty Products & Technologies |  | Equipment & Consumables |  | Total |  | Specialty Products & Technologies |  | Equipment & Consumables |  | Total
Sales | $ | 471.0 |  |  | $ | 259.5 |  |  | $ | 730.5 |  |  | $ | 445.1 |  |  | $ | 237.0 |  |  | $ | 682.1 |
Less: |  |  |  |  |  |  |  |  |  |  |
Expenses | 410.9 |  |  | 213.6 |  |  | 624.5 |  |  | 399.8 |  |  | 200.9 |  |  | 600.7 |
Segment operating profit | $ | 60.1 |  |  | $ | 45.9 |  |  | $ | 106.0 |  |  | $ | 45.3 |  |  | $ | 36.1 |  |  | $ | 81.4 |
Segment operating profit and reconciliation to income before taxes: |  |  |  |  |  |  |  |  |  |  |
Segment operating profit |  |  |  |  | $ | 106.0 |  |  |  |  |  |  | $ | 81.4 |
Corporate and other |  |  |  |  | (25.7) |  |  |  |  |  |  | (35.1) |
Nonoperating other income, net |  |  |  |  | 2.8 |  |  |  |  |  |  | 2.4 |
Interest expense, net |  |  |  |  | (8.7) |  |  |  |  |  |  | (8.0) |
Income before taxes |  |  |  |  | $ | 74.4 |  |  |  |  |  |  | $ | 40.7 |
Depreciation and amortization |  |  |  |  |  |  |  |  |  |  |
Specialty Products & Technologies |  |  |  |  | $ | 22.0 |  |  |  |  |  |  | $ | 22.0 |
Equipment & Consumables |  |  |  |  | 5.5 |  |  |  |  |  |  | 7.4 |
Corporate and other |  |  |  |  | 0.3 |  |  |  |  |  |  | 0.4 |
Total |  |  |  |  | $ | 27.8 |  |  |  |  |  |  | $ | 29.8 |
Capital expenditures, gross |  |  |  |  |  |  |  |  |  |  |
Specialty Products & Technologies |  |  |  |  | $ | 11.9 |  |  |  |  |  |  | $ | 6.7 |
Equipment & Consumables |  |  |  |  | 3.0 |  |  |  |  |  |  | 4.4 |
Corporate and other |  |  |  |  | — |  |  |  |  |  |  | (0.2) |
Total |  |  |  |  | $ | 14.9 |  |  |  |  |  |  | $ | 10.9 |
| Six Months Ended July 3, 2026 |  | Six Months Ended June 27, 2025
| Specialty Products & Technologies |  | Equipment & Consumables |  | Total |  | Specialty Products & Technologies |  | Equipment & Consumables |  | Total
Sales | $ | 928.8 |  |  | $ | 507.2 |  |  | $ | 1,436.0 |  |  | $ | 845.4 |  |  | $ | 453.6 |  |  | $ | 1,299.0 |
Less: |  |  |  |  |  |  |  |  |  |  |
Expenses | 822.2 |  |  | 414.5 |  |  | 1,236.7 |  |  | 762.5 |  |  | 385.6 |  |  | 1,148.1 |
Segment operating profit | $ | 106.6 |  |  | $ | 92.7 |  |  | $ | 199.3 |  |  | $ | 82.9 |  |  | $ | 68.0 |  |  | $ | 150.9 |
Segment operating profit and reconciliation to income before taxes: |  |  |  |  |  |  |  |  |  |  |
Segment operating profit |  |  |  |  | $ | 199.3 |  |  |  |  |  |  | $ | 150.9 |
Corporate and other |  |  |  |  | (56.5) |  |  |  |  |  |  | (65.6) |
Nonoperating other expense, net |  |  |  |  | (0.1) |  |  |  |  |  |  | 1.7 |
Interest expense, net |  |  |  |  | (16.1) |  |  |  |  |  |  | (17.3) |
Income before taxes |  |  |  |  | $ | 126.6 |  |  |  |  |  |  | $ | 69.7 |
Depreciation and amortization |  |  |  |  |  |  |  |  |  |  |
Specialty Products & Technologies |  |  |  |  | $ | 44.4 |  |  |  |  |  |  | $ | 42.6 |
Equipment & Consumables |  |  |  |  | 11.7 |  |  |  |  |  |  | 14.3 |
Corporate and other |  |  |  |  | 0.9 |  |  |  |  |  |  | 0.8 |
Total |  |  |  |  | $ | 57.0 |  |  |  |  |  |  | $ | 57.7 |
Capital expenditures, gross |  |  |  |  |  |  |  |  |  |  |
Specialty Products & Technologies |  |  |  |  | $ | 20.1 |  |  |  |  |  |  | $ | 10.4 |
Equipment & Consumables |  |  |  |  | 6.3 |  |  |  |  |  |  | 7.9 |
Corporate and other |  |  |  |  | — |  |  |  |  |  |  | 0.1 |
Total |  |  |  |  | $ | 26.4 |  |  |  |  |  |  | $ | 18.4 |
Identifiable assets | July 3, 2026 |  | December 31, 2025
Specialty Products & Technologies | $ | 2,563.6 |  |  | $ | 2,488.3 |
Equipment & Consumables | 1,875.1 |  |  | 1,942.1 |
Corporate and other | 1,158.4 |  |  | 1,248.6 |
Total | $ | 5,597.1 |  |  | $ | 5,679.0 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for segment reporting. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 15: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 18: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 19: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 20: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 21: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 22: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/280/tableOfContent Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration